Women’s health trial expansion

Belgrade University Medical School

Belgrade University Medical School

Phase IIIb preterm delivery study expands to additional locations in Serbia, Romania, and Bulgaria under GCT management, making our team responsible for this project at 45 sites in 7 countries.

The Sponsor, a US pharmaceutical company, thus shows confidence in GCT international capabilities and local expertise.

Updated: August 28, 2015

Permanent link: https://2022.gctrials.com/news/womens-health-trial-expansion/

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2021 Global Clinical Trials, LLC

All rights reserved.